接纳承诺疗法治疗失眠:随机对照试验的更新版荟萃分析
Acceptance and commitment therapy for insomnia: an updated meta-analysis of randomized controlled trials.
一句话摘要
更新版系统综述与荟萃分析:与等待名单/常规对照相比,接纳承诺疗法(ACT)对失眠严重度的改善为中到大效应(SMD −0.67);ACT 与 CBT-I 在治疗后(SMD 0.21)与 6 个月随访(0.14)均无显著差异。
为什么重要
为「ACT 能否作为 CBT-I 的替代」提供量化答案:疗效接近、可作备选,但缓解率等指标仍偏向 CBT-I。
英文摘要原文
Purpose To evaluate the effects of acceptance and commitment therapy (ACT) for insomnia compared with waitlist/standard control conditions and cognitive behavioral therapy for insomnia (CBT-I). Methods A systematic review and meta-analysis of randomized controlled trials was conducted. We searched on PubMed, Embase, and the Cochrane Library for studies comparing ACT or ACT-based interventions with non-ACT conditions in patients with insomnia. Continuous outcomes were pooled using a restricted maximum likelihood random-effects model on R. Results ACT showed moderate-to-large improvement in insomnia symptom severity compared with waitlist/standard controls (SMD - 0.67, 95% CI - 1.08 to - 0.25). We observed no significant difference in insomnia severity between ACT and CBT-I at posttreatment (SMD 0.21, 95% CI - 0.02 to 0.43) or at 6-month follow-up (SMD 0.14, 95% CI - 0.15 to 0.42). CBT-I showed significant improvement in remission (ISI 7-point ISI reduction) did also not differ significantly. Compared with waitlist/standard control, ACT produced a small-to-moderate reduction in depression (SMD - 0.34, 95% CI - 0.57 to - 0.12) and anxiety symptoms (SMD - 0.42, 95% CI - 0.67 to - 0.17). Conclusion ACT can be an efficacious treatment for insomnia with particularly strong outcomes for its psychological symptoms. Nevertheless, CBT-I remains the gold standard due to its more extensive and consistent evidence base.
所属章节
条目编号 P172 · 元数据经 Crossref / Europe PMC 回查